<i>Pck1</i> Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in <i>db/db</i> Mice

Abstract

Our observations indicate that silencing PEPCK-C has direct impact on glycemia control and energy metabolism and provides new insights into the potential significance of the enzyme as a therapeutic target for the treatment of diabetes.